Recent ADTX News
- Form S-3 - Registration statement under Securities Act of 1933 • Edgar (US Regulatory) • 07/11/2024 08:30:45 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 07/09/2024 09:09:54 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 07/08/2024 10:25:49 AM
- Hello Alpha Partners with Evofem to Offer Phexxi® as a Hormone-Free Contraception Solution on its Platform for Women's Healthcare • PR Newswire (US) • 06/27/2024 12:36:00 PM
- Form 424B3 - Prospectus [Rule 424(b)(3)] • Edgar (US Regulatory) • 06/14/2024 08:01:28 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 06/12/2024 08:35:45 PM
- Form PRER14A - Preliminary Proxy Soliciting materials • Edgar (US Regulatory) • 06/07/2024 09:12:12 PM
- Form PRE 14A - Other preliminary proxy statements • Edgar (US Regulatory) • 05/29/2024 08:33:17 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 05/28/2024 10:08:41 AM
- Form 8-K - Current report • Edgar (US Regulatory) • 05/22/2024 08:24:20 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 05/20/2024 08:15:45 PM
- Evofem Biosciences Announces Financial Results for the First Quarter of 2024 • PR Newswire (US) • 05/15/2024 10:50:00 AM
- Form 8-K - Current report • Edgar (US Regulatory) • 05/13/2024 08:15:21 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 05/08/2024 08:15:21 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 05/07/2024 08:15:44 PM
- CORRECTING and REPLACING Aditxt Announces Pricing of $4.2 Million Private Placement Priced At-The-Market under Nasdaq Rules • Business Wire • 05/03/2024 06:14:00 PM
- Aditxt Announces Pricing of $4.2 Million Private Placement Priced At-The-Market under Nasdaq Rules • Business Wire • 05/03/2024 01:00:00 PM
- Aditxt Signs a Definitive Agreement to Acquire Appili Therapeutics Inc., Developer of a Biodefense Vaccine Funded by the U.S. Department of Defense (DoD) • Business Wire • 04/02/2024 12:30:00 PM
- Evofem Reports $18.2 million of Phexxi Net Product Sales in 2023 • PR Newswire (US) • 03/27/2024 12:36:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 03/11/2024 08:51:37 PM
- For Women Using GLP-1 Receptor Agonists who take Oral Birth Control Pills, Hormone-Free Phexxi Contraceptive Gel is a Logical Solution to Help Prevent Unintended Pregnancy • PR Newswire (US) • 03/07/2024 12:54:00 PM
- Form 425 - Prospectuses and communications, business combinations • Edgar (US Regulatory) • 03/04/2024 10:27:42 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 03/04/2024 10:24:56 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 03/01/2024 09:01:19 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 02/29/2024 09:01:59 PM
FEATURED Cannabix Technologies and Omega Laboratories Inc. Provide Positive Developments on Marijuana Breathalyzer Testing • Jul 11, 2024 8:21 AM
ECGI Holdings Enhances Board with Artificial Intelligence (AI) Expert Ahead of Allon Apparel Launch • ECGI • Jul 10, 2024 8:30 AM
Avant Technologies to Meet Unmet Needs in AI Industry While Addressing Sustainability Concerns • AVAI • Jul 10, 2024 8:00 AM
Panther Minerals Inc. Launches Investor Connect AI Chatbot for Enhanced Investor Engagement and Lead Generation • PURR • Jul 9, 2024 9:00 AM
Glidelogic Corp. Becomes TikTok Shop Partner, Opening a New Chapter in E-commerce Services • GDLG • Jul 5, 2024 7:09 AM
Freedom Holdings Corporate Update; Announces Management Has Signed Letter of Intent • FHLD • Jul 3, 2024 9:00 AM